References
- Cheng, T.O. Cardiovascular effects of Danshen. Into J Cardio 2007; 121: 9–22.
- Zhou, L.Z., Zoo, Z., Chow, M.S. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clint Pharmacology 2005; 45: 1345–59.
- Adams, J.D., Wang, R., Yang J., et al. Preclinical and clinical examinations of Salvia miltiorrhiza and its tensions in ischemic conditions. Chin Med 2006; 1: 3.
- Liu, J.R., Chen, G.F., Shih, H.N., et al. Enhanced antioxidant bioactivity of Salvia miltiorrhiza (Danshen) products prepared using nanotechnology. Phytomedicine 2008; 15: 23–30.
- Xiaohui, Z., Xinfeng, Z., Xin, Z., et al. Determination of the main bioactive metabolites of Radix salvia miltiorrhizae in compound Danshen dripping pills and the tissue distribution of Danshensu in rabbit by SPE-HPLC-MSn. J Sep Sci 2007; 30: 851–7.
- Herkel, J., Schuchmann, M., Tiegs, G., et al. Immune-mediated liver injury. J Hepatol 2005; 42: 920–3.
- Center, S.A. Chronic liver disease: current concepts of disease mechanisms. J Small Anim Pract 1999; 40: 106–14.
- Gantner, F., Leist, M., Lohse, A.W., et al. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology, 1995; 21: 190–8.
- Abboud, G., Kaplowitz, N. Drug-induced liver injury. Drug Saf 2007; 30: 277–94.
- Eksteen, B., et al. Immune-mediated liver injury. Semin Liver Dis 2007; 27: 351–66.
- Kremer, A.E., Rust, C., Eichhorn, P., et al. Immune-mediated liver diseases: programmed cell death ligands and circulating apoptotic markers. Expert Rev Mol Diagn 2009; 9: 139–56.
- Beldi, G., Banz, Y., Nowak, M., et al. Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis. Hepatology 2008; 48: 841–52.
- Huang, W., Dong, Z., Wei H., et al. Selective elimination of hepatic natural killer T cells with concanavalin A improves liver regeneration in mice. Liver Int 2006; 26: 339–45.
- Irshad, M. I., Khushboo, I., Singh, S. Hepatitis C virus (HCV): a review of immunological aspects. Int Rev Immunol 2008; 27: 497–517.
- Ju, C. Immunological mechanisms of drug-induced liver injury. Curr Opin Drug Discov Dev 2005; 8: 38–43.